Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tempero

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Journal of Clinical Immunology|January 1, 1997
Antiidiotypic response against murine monoclonal antibodies reactive with tumor-associated antigen TAG-72I Blanco, R Kawatsu, K Harrison, et al.
Cancer Research|October 1, 1988
Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group typeP M Pour, M M Tempero, H Takasaki, et al.
Plos One|November 11, 2014
Nerve growth factor regulates neurolymphatic remodeling during corneal inflammation and resolutionDarci M Fink, Alicia L Connor, Philip M Kelley, et al.
Oncology (Williston Park, N.Y.)|November 1, 1996
NCCN Colorectal Cancer Practice Guidelines. The National Comprehensive Cancer NetworkP F Engstrom, A B Benson, A Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: a phase I trialM Tempero, P Leichner, G Dalrymple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trialM Tempero, P Leichner, J Baranowska-Kortylewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
Single-Dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using 131I-labeled multivalent CC49 single-chain fvsA Goel, S Augustine, J Baranowska-Kortylewicz, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 1999
Organ-specific pancreatic tumor growth properties and tumor immunityK Morikane, R M Tempero, C L Sivinski, et al.
Hybridoma|July 1, 1986
Anti-idiotypic antibodies to monoclonal antibody CO17-1AD Herlyn, H Sears, D Iliopoulos, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 25, 2010
Lymphatic malformations: current cellular and clinical investigationsJonathan A Perkins, Scott C Manning, Richard M Tempero, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Clinical Immunology|January 1, 1997
Antiidiotypic response against murine monoclonal antibodies reactive with tumor-associated antigen TAG-72I Blanco, R Kawatsu, K Harrison, et al.
Cancer Research|October 1, 1988
Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group typeP M Pour, M M Tempero, H Takasaki, et al.
Plos One|November 11, 2014
Nerve growth factor regulates neurolymphatic remodeling during corneal inflammation and resolutionDarci M Fink, Alicia L Connor, Philip M Kelley, et al.
Oncology (Williston Park, N.Y.)|November 1, 1996
NCCN Colorectal Cancer Practice Guidelines. The National Comprehensive Cancer NetworkP F Engstrom, A B Benson, A Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: a phase I trialM Tempero, P Leichner, G Dalrymple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trialM Tempero, P Leichner, J Baranowska-Kortylewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
Single-Dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using 131I-labeled multivalent CC49 single-chain fvsA Goel, S Augustine, J Baranowska-Kortylewicz, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 1999
Organ-specific pancreatic tumor growth properties and tumor immunityK Morikane, R M Tempero, C L Sivinski, et al.
Hybridoma|July 1, 1986
Anti-idiotypic antibodies to monoclonal antibody CO17-1AD Herlyn, H Sears, D Iliopoulos, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 25, 2010
Lymphatic malformations: current cellular and clinical investigationsJonathan A Perkins, Scott C Manning, Richard M Tempero, et al.
Pageof 5